Jon Cuthbert - Author on Grafa

SunRice Group (ASX:SGLLV) has delivered a solid first-half performance for FY26, posting a 14% increase in net profit after tax to $36.6 million.

Terrain Minerals (ASX:TMX) announced a temporary pause in its 2025 reverse circulation drilling campaign at Smokebush Gold Project.

5E Advanced Materials (ASX:5EA) filed a foundational patent application with the US Patent and Trademark Office for its proprietary closed-loop in-situ leach boron mining and production process.

Boss Energy (ASX:BOE) has concluded its Honeymoon review and announced a new feasibility study.

Buru Energy (ASX:BRU) has provided an update on its 100% owned Rafael Gas Project.

Renegade Exploration (ASX:RNX) has signed a lease and option agreement granting it exclusive rights to explore and potentially acquire the Rooster Hill Monazite Project.

Former Alameda Research chief executive Caroline Ellison has been transferred from federal prison to a reentry facility ahead of an early release, highlighting her cooperation in the FTX case and renewed public attention on the exchange’s collapse.

Bapcor (ASX:BAP) announced that Chris Wilesmith will succeed Angus McKay as CEO and Managing Director.

APA Group (ASX:APA) has announced the execution of a binding agreement to sell its 20% equity stake in GDI.

Traws Pharma (NASDAQ:TRAW) reported promising interim results from its Phase 2 trial of ratutrelvir, a ritonavir-free Mpro inhibitor, in the treatment of COVID-19.

The oral treatment, administered at a 600 mg once-daily dose for 10 days, was compared against PAXLOVID™ in a randomized, open-label study involving 37 patients—25 receiving ratutrelvir and 12 receiving PAXLOVID™.